Safinamide for treating myotonia
AssigneeZambon S.p.A.
InventorsJean-François Desaphy, Sabata Pierno, Diana Conte, Elsa Melloni, Silvia Vailati, Gloria Padoani, Carla Caccia
Life of this patent
Estimating the term…
Abstract
The present invention relates to safmamide or a pharmaceutically acceptable salt thereof for use in the treatment of a condition caused by pathological sarcolemma hyperexcitability, and/or of any other condition in which the restoration of normal sarcolemma excitability may produce a therapeutic benefit or improvement, wherein said condition is preferably a myotonic disorder.
Claims18
Method of treating myotonic disorders in patients in need thereof, said method comprising
- administering to said patients a pharmaceutically effective amount of safinamide or a pharmaceutically acceptable salt thereof and treating said patients of said myotonic disorders.
Method of treating myotonic disorders in patients in need thereof, said method comprising
- administering to said patients a pharmaceutically acceptable amount of A pharmaceutical composition comprising safinamide or a pharmaceutically acceptable salt thereof in combination with a pharmaceutical carrier and/or excipient, and treating said patients of said myotonic disorders.
Method of treating myotonic disorders or relieving symptoms thereof in patients in need thereof, said method comprising
- administering to said patients a pharmaceutically effective amount of a medicament comprising safinamide and treating said patients of said myotonic disorders or relieving symptoms thereof.
Dependencies are inferred from the claim text.